EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cellular and Molecular Mechanisms of Berberine in Cancer Therapy: Recent Advances

Kang He iD, Bing-Rui Lu iD, Xu-Ying Shi iD, Run-Long Sui iD, Zhi-Gang Sun iD

Archiv der Pharmazie · 2026-08 · 359 (8)

DOI: 10.1002/ardp.70313 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 17.08.2026. Verfasst von Kang He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Berberine, Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 158 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shandong Provincial Medical and Health Science and Technology Project, Science and Technology Development Plan Project of Jinan Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the role of traditional Chinese medicine (TCM) in comprehensive cancer treatment has become increasingly prominent, gradually emerging as an important adjunctive modality alongside conventional therapies such as surgery, chemotherapy, and radiotherapy, and attracting widespread attention. Berberine, an isoquinoline alkaloid extracted from natural plants such as Coptis chinensis , possesses broad‐spectrum and potent pharmacological activities. A large body of evidence has demonstrated that berberine exerts definite antitumor effects in various cancer models, with its mechanisms of action spanning multiple dimensions, including cell‐cycle arrest, induction of cell death, modulation of the tumor microenvironment (TME), inhibition of invasion and metastasis, and intervention in angiogenesis. Based on the latest research progress worldwide, this review focuses on key oncogenic signaling pathways and immune regulatory mechanisms to systematically elucidate the cellular and molecular mechanisms underlying the antitumor activity of berberine, and further discusses its clinical application potential and the challenges ahead. Although the clinical translation of berberine remains constrained by bottlenecks such as formulation optimization and bioavailability enhancement, its broad prospects in the field of cancer prevention and treatment establish it as a highly valuable TCM‐derived antitumor candidate for further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineNeoplasmsAntineoplastic Agents, PhytogenicHumansAnimalsMedicine, Chinese TraditionalSignal TransductionTumor Microenvironment

Stichwörter der Autor:innen

berberinecancercellular mechanismmolecular mechanismtraditional Chinese medicine

Substanzen

BerberineAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

ORCID-Profile: Kang He, Bing-Rui Lu, Xu-Ying Shi, Run-Long Sui, Zhi-Gang Sun

Förderung

  • Shandong Provincial Medical and Health Science and Technology Project
  • Science and Technology Development Plan Project of Jinan Municipal Health Commission

Zitieren

APA

He, K., Lu, B. R., Shi, X. Y., Sui, R. L., & Sun, Z. G. (2026). Cellular and Molecular Mechanisms of Berberine in Cancer Therapy: Recent Advances. Archiv der Pharmazie, 359(8). https://doi.org/10.1002/ardp.70313

Vancouver

He K, Lu BR, Shi XY, Sui RL, Sun ZG. Cellular and Molecular Mechanisms of Berberine in Cancer Therapy: Recent Advances. Archiv der Pharmazie. 2026;359(8). doi:10.1002/ardp.70313

BibTeX
@article{He2026,
  author = {He, Kang and Lu, Bing-Rui and Shi, Xu-Ying and Sui, Run-Long and Sun, Zhi-Gang},
  title = {Cellular and Molecular Mechanisms of Berberine in Cancer Therapy: Recent Advances},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {8},
  doi = {10.1002/ardp.70313}
}
Kostenlos starten →